Annual balance sheet for Instil Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 454 | 261 | 150 | 113 | 76.1 |
| Net Total Receivables | — | — | — | — | 0.848 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 464 | 269 | 161 | 124 | 191 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 122 | 209 | 141 | 130 | 0.364 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 610 | 482 | 326 | 264 | 204 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 41.4 | 32.8 | 10.6 | 7.9 | 4.84 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 54.8 | 119 | 99.8 | 94.1 | 89.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 555 | 364 | 226 | 169 | 114 |
| Total Liabilities & Shareholders' Equity | 610 | 482 | 326 | 264 | 204 |
| Total Common Shares Outstanding |